From Assay to Action – Making MRD a Practical Tool for Treatment Decisions in Hematology

  • Bridging assay development and translational research to define clinically meaningful MRD cut-offs and endpoints
  • Designing MRD-guided clinical trials to inform treatment decisions, including escalation, consolidation & de-escalation strategies
  • Addressing turnaround time, cost and implementation challenges to ensure MRD assays can move from trials into routine practice